Live from the NIH registry
Studies recruiting near Santa Rosa right now
Top 25 of 145 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Santa Rosa, California (0.6 mi)
· Sponsor: AstraZeneca
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
North Bay Eye Associates /ID# 277071 — Petaluma, California (15.2 mi)
· Sponsor: AbbVie
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Napa, California (25.0 mi)
· Sponsor: Medtronic
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
MISHA Post-Market Clinical Study
Osteo Arthritis Knee
N/A
Interventional 120 participants sought
Weiss Orthopedics — Sonoma, California (17.2 mi)
· Sponsor: Moximed
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Airway Drive Care Center — Santa Rosa, California (0.6 mi)
· Sponsor: Pfizer
Mental Health in Veterans and Families After Group Therapies
Post-Traumatic Stress Disorders
EARLY/Phase 1
Interventional 100 participants sought
Soul Medicine Institute — Santa Rosa, California (0.6 mi)
· Sponsor: Soul Medicine Institute
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 686 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Daiichi Sankyo
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Adjustment Disorder
Phase 2
Interventional 100 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Reunion Neuroscience Inc
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Peripheral Vascular Diseases
N/A
Observational 5,000 participants sought
Adventist Health St Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: Boston Scientific Corporation
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Atherosclerosis
Phase 2
Interventional 162 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi)
· Sponsor: Genentech, Inc.
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
One of a Kind Clinical Research Center — Napa, California (25.0 mi)
· Sponsor: Celldex Therapeutics
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 1
Interventional 304 participants sought
Research Site — Santa Rosa, California (0.6 mi)
· Sponsor: AstraZeneca
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
NorthBay Clinical Research- Site Number : 8400066 — Santa Rosa, California (0.6 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Inhibrx Biosciences, Inc
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Advanced Cancer, Metastatic Cancer
Phase 1, Phase 2
Interventional 542 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Artios Pharma Ltd